These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31390256)

  • 1. Working Toward Broad and Equitable Access to HIV Preexposure Prophylaxis.
    Marcus JL; Krakower DS
    Am J Public Health; 2019 Sep; 109(9):1160-1161. PubMed ID: 31390256
    [No Abstract]   [Full Text] [Related]  

  • 2. Geographic Access to Preexposure Prophylaxis and the Case for Telemedicine.
    Wong KYK; Klausner JD
    Am J Public Health; 2020 Jan; 110(1):e3. PubMed ID: 31800289
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV Preexposure Prophylaxis and Sexual Satisfaction Among Men Who Have Sex With Men.
    Marcus JL; Sewell WC; Powell VE; Ochoa A; Mayer KH; Krakower DS
    Sex Transm Dis; 2021 Oct; 48(10):e135-e137. PubMed ID: 33657578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the United States Ready for Event-Driven Human Immunodeficiency Virus Preexposure Prophylaxis?
    Cohen SE; Kelley CF
    Clin Infect Dis; 2020 Jul; 71(2):256-258. PubMed ID: 31436811
    [No Abstract]   [Full Text] [Related]  

  • 5. Preexposure prophylaxis is effective on a national level, but is it enough.
    Kojima N; Klausner JD
    AIDS; 2021 Mar; 35(4):691-692. PubMed ID: 33620874
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-exposure prophylaxis is cost-effective for HIV in the UK.
    Revill P; Dwyer E
    Lancet Infect Dis; 2018 Jan; 18(1):10-11. PubMed ID: 29054788
    [No Abstract]   [Full Text] [Related]  

  • 7. New preexposure prophylaxis options need updated counseling approaches: reframing 'risk' in HIV prevention counseling for young sexual and gender minorities of color.
    Maragh-Bass AC; Stoner MCD; Castellanos-Usigli A; Agarwal H; Katz AWK; Patani H; Sukhija-Cohen A; Campbell L; Arreola S; Saberi P
    AIDS; 2023 Jul; 37(9):1361-1366. PubMed ID: 37070546
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel Approaches for Development of Human Immunodeficiency Virus Preexposure Prophylaxis Agents.
    Cohen MS; Donnell D
    J Infect Dis; 2020 Jan; 221(2):172-174. PubMed ID: 30715403
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient Disengagement From an HIV Preexposure Prophylaxis Program in a Sexually Transmitted Disease Clinic.
    Dombrowski JC; Golden MR; Barbee LA; Khosropour CM
    Sex Transm Dis; 2018 Sep; 45(9):e62-e64. PubMed ID: 29485544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Being PrEPared - Preexposure Prophylaxis and HIV Disparities.
    Goldstein RH; Streed CG; Cahill SR
    N Engl J Med; 2018 Oct; 379(14):1293-1295. PubMed ID: 30230965
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges in optimizing preexposure prophylaxis development, engagement, and access for HIV prevention.
    Scully EP; Weld ED; Blankson JN
    J Clin Invest; 2019 Dec; 129(12):5071-5073. PubMed ID: 31710315
    [No Abstract]   [Full Text] [Related]  

  • 12. HCV infection in HIV-negative MSM using HIV pre-exposure prophylaxis (PrEP)-Another piece of the jigsaw.
    Bhagani S
    Liver Int; 2018 Oct; 38(10):1733-1735. PubMed ID: 30256512
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription of Preexposure Prophylaxis to Men Who Have Sex With Men Diagnosed and Reported With Gonorrhea, STD Surveillance Network, 2016.
    Ramirez V; Han E; Stoltey J; Nguyen TQ; Pathela P; Tourdot L; Walters J; Bell T; Torrone E; Stenger M
    Sex Transm Dis; 2018 Aug; 45(8):e57-e60. PubMed ID: 29465634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'On December 1, 2015, sex changes. Forever': Pre-exposure prophylaxis and the pharmaceuticalisation of the neoliberal sexual subject.
    Thomann M
    Glob Public Health; 2018 Aug; 13(8):997-1006. PubMed ID: 29368990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical importance of retention in HIV prevention.
    Golub SA; Enemchukwu CU
    Lancet HIV; 2018 Sep; 5(9):e475-e476. PubMed ID: 29908918
    [No Abstract]   [Full Text] [Related]  

  • 16. Error in the calculation of person-time in the before-PrEP period by Beymer
    Hulstein SH; Hoornenborg E; van der Loeff MFS
    Sex Transm Infect; 2018 Nov; 94(7):514. PubMed ID: 30337430
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving Forward With Treatment of Gonorrhea for Users of Human Immunodeficiency Virus Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.
    Jenness SM; Weiss KM; Goodreau SM; Gift T; Chesson H; Hoover KW; Smith DK; Liu AY; Sullivan PS; Rosenberg ES
    Clin Infect Dis; 2018 Jun; 67(1):155-156. PubMed ID: 29370356
    [No Abstract]   [Full Text] [Related]  

  • 19. PrEP Whores and HIV Prevention: The Queer Communication of HIV Pre-Exposure Prophylaxis (PrEP).
    Spieldenner A
    J Homosex; 2016 Dec; 63(12):1685-1697. PubMed ID: 26930025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Possible Nonmedical Risks of Preexposure Prophylaxis Prescription in Adolescents.
    Algarin AB; Ibañez GE
    JAMA Pediatr; 2018 Apr; 172(4):391. PubMed ID: 29435571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.